Improved efficacy in onychomycosis therapy
Authors:
- Aditya K. GuptaAditya K. Gupta
- Maryse PaquetMPMaryse Paquet
- 1 September 2013
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 31 (5) , 555-563
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Susceptibility testing of terbinafine alone and in combination with amphotericin B, itraconazole, or voriconazole against conidia and hyphae of dematiaceous moldsDiagnostic Microbiology and Infectious Disease, 2011
- Standardization of Hyphal Growth Inhibition Rate as a Means of Evaluating Microsporum spp. in vitro Susceptibility to Terbinafine, Griseofulvin, and CiclopiroxolamineMycopathologia, 2011
- Onychomycosis: Diagnosis and managementIndian Journal of Dermatology, Venereology and Leprology, 2011
- New insights into the effect of amorolfine nail lacquerMycoses, 2005
- Comparison of In Vitro Antifungal Susceptibilities of Conidia and Hyphae of Dermatophytes with Thick-Wall MacroconidiaAntimicrobial Agents and Chemotherapy, 2003
- Treatment Failures and Relapses in Onychomycosis: A Stubborn Clinical ProblemDermatology, 2003
- A Plea to Bridge the Gap Between Antifungals and the Management of OnychomycosisAmerican Journal of Clinical Dermatology, 2001
- The Boosted Oral Antifungal Treatment for Onychomycosis beyond the Regular Itraconazole Pulse Dosing RegimenDermatology, 2000
- The boosted antifungal topical treatment (BATT) for onychomycosisMedical Mycology, 2000
- Facing up to the diagnostic uncertainty and management of onychomycosesInternational Journal of Dermatology, 1999